Cipla Ltd. — Regulatory Filings 2020

Jul 13, 2020

13[th] July 2020

(1) BSE Ltd (2) National Stock Exchange of India Ltd Listing Department Listing Department Phiroze Jeejeebhoy Towers, Exchange Plaza, 5[th] floor, Dalal Street, Plot no. C/1, G Block, Mumbai - 400 001 Bandra Kurla Complex, Bandra (East), Mumbai - 400 051

Scrip Code: 500087 Scrip Code: CIPLA EQ

• (3) SOCIETE DE LA BOURSE DE LUXEMBOURG Societe Anonyme 35A Boulevard Joseph II, L-1840 Luxembourg

Sub: Update on the Definitive Agreement entered between Cipla Technologies LLC and Pulmatrix for Development and Commercialization of Pulmazole

Dear Sir / Madam,

On April 15, 2019 Cipla Limited reported its US subsidiary Cipla Technologies LLC (CipTec) entering into a definitive agreement (Agreement) with Pulmatrix, Inc., USA (Pulmatrix) for the co-development and commercialization of Pulmazole ( PUR 1900 ) an inhaled iSPERSE™ formulation of the antifungal drug Itraconazole; for the treatment of allergic bronchopulmonary aspergillosis (ABPA) for patients with asthma.

Discussions to renegotiate the terms of the Agreement are now in progress. Due to the delays in patient enrolment for the Phase 2a clinical study managed by Pulmatrix, the Joint Steering Committee has terminated the Phase 2a clinical study in order to commence a new Phase 2b study with longer dose duration and efficacy endpoints, upon Agreement negotiations with Pulmatrix being successful. It's Cipla’s position that under the terms of the Agreement it has the right to suspend additional funding under certain circumstances. The renegotiated agreement may include, amongst other things a reallocation of costs and a grant of rights to CipTec (and/or its affiliates) to develop and commercialize Pulmazole in select markets outside the United States. Updates on this amendment to the Agreement and other related developments will be provided in the future.

Kindly acknowledge the receipt

This is for your information and records.

Thanking you,

Yours faithfully, For Cipla Limited

RAJENDRA CHOPRA Digitally signed by RAJENDRA CHOPRA DN: c=IN, o=Personal, 2.5.4.20=4987ad48c3965cfde78c8ea69e6f40ac91535876f12ba1fa5ba45cc5cc8db6cb, postalCode=122001, st=HARYANA, serialNumber=0be85c0408d0e3afd663669f5314248a72fdcdf34d01d48d472d7cf9262696f6, cn=RAJENDRA CHOPRA Date: 2020.07.13 21:16:04 +05'30'

Rajendra Chopra Company Secretary

Prepared by: Juzer Masta